Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Harper
Thomas Harper
Boehringer Ingelheim
Asthma
Respimat
Medicine
Physical therapy
Placebo
4
Papers
122
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of tiotropium in children aged 1–5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial
2018
The Lancet Respiratory Medicine
Elianne J.L.E. Vrijlandt
Georges El Azzi
Mark Vandewalker
Ned Rupp
Thomas Harper
Leroy Graham
Stanley J. Szefler
Petra Moroni-Zentgraf
Ashish Sharma
Sebastian Dan Vulcu
Ralf Sigmund
Bo L. Chawes
Michael Engel
Hans Bisgaard
Show All
Source
Cite
Save
Citations (43)
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma
2017
The Journal of Allergy and Clinical Immunology
Stanley J. Szefler
Kevin R. Murphy
Thomas Harper
Attilio L. Boner
István Laki
Michael Engel
Georges El Azzi
Petra Moroni-Zentgraf
Helen Finnigan
Eckard Hamelmann
Show All
Source
Cite
Save
Citations (77)
Once-daily tiotropium Respimat® add-on therapy improves PEF in participants aged 6-17 years with symptomatic asthma
2016
European Respiratory Journal
Eckard Hamelmann
Christian Vogelberg
Jonathan A. Bernstein
Thomas Harper
Petra Moroni-Zentgraf
Michael Engel
Georges El Azzi
Helen Finnigan
Stanley J. Szefler
Show All
Source
Cite
Save
Citations (1)
Once-Daily Tiotropium Respimat Add-on to Inhaled Corticosteroids Over 1 Year Improves Lung Function in Adolescent Patients With Moderate Symptomatic Asthma, Independent of Patients Baseline Characteristics
2015
Chest
Mark Vandewalker
Thomas Harper
Petra Moroni-Zentgraf
Michael Engel
Reinhold Luehmann
Jonathan A. Bernstein
Show All
Source
Cite
Save
Citations (1)
1